ITGAM and neoplasm: In mice, the presence of thymoma, breast, colon, and melanoma cell line-derived subcutaneous tumors led to inhibited NK cell development in the bone marrow, as evidenced by reduced mature NK1.1+CD11b+ NK cell fractions in tumor bearing mice compared to controls (21).